scispace - formally typeset
Open AccessJournal ArticleDOI

Advances in antitumor effects of NSAIDs.

Reads0
Chats0
TLDR
The progress of the application of NSAIDs, especially aspirin, in the prevention and treatment of tumors in recent years is summarized, and new ideas and directions for the follow-up study are also discussed.
Abstract
In recent years, the reports on using nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer prevention and treatment have been on the rise. In 2017, the US Preventive Services Working Group issued primary prevention guidelines on the use of NSAIDs, especially aspirin, for cardiovascular disease and colorectal cancer, and formally established the role and status of aspirin in cancer prevention. However, the mechanism of NSAIDs on preventing cancer is still not clear. In this paper, the progress of the application of NSAIDs, especially aspirin, in the prevention and treatment of tumors in recent years is summarized, and new ideas and directions for the follow-up study are also discussed.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective.

TL;DR: The present review provides a comprehensive insight of the existing knowledge and recent developments on NSAID-induced organ damage while reiterating on the emerging instances of NSAID drug repurposing along with pharmacophore modification aimed at safer usage of NSAIDs where toxic effects are tamed without compromising the clinical benefits.
Journal ArticleDOI

Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.

TL;DR: The administration of NSAIDs in cancer treatment would appear to be an interesting therapeutic strategy, which acts through their role in regulating WNT/β-catenin pathway and PPARγ activity levels.
Journal ArticleDOI

New drugs are not enough‑drug repositioning in oncology: An update.

TL;DR: The present review summarizes the most prominent examples of drug repositioning for the treatment of cancer, taking into consideration their primary use, proposed anticancer mechanisms and current development status.
Journal ArticleDOI

Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer.

TL;DR: E Epidemiological investigations and basic research using human immune cells or mouse models have revealed that non-steroidal anti-inflammatory drugs, metformin, statins, soy isoflavones, and other diets are potential interventions for preventing progression of prostate cancer by suppressing inflammation.
Journal ArticleDOI

Amending microbiota by targeting intestinal inflammation with TNF blockade attenuates development of colorectal cancer.

TL;DR: The role of microbiota is established in mediating the antitumorigenic effect of anti-tumor necrosis factor (TNF) therapy and microbiota transplantation showed reduced carcinogenic activity of microbiota from anti-TNF-treated mice, demonstrating the plasticity of microbiota, which could be reverted to noncarcinogenic status by targeting inflammation.
References
More filters
Journal ArticleDOI

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.

TL;DR: This work surmises that CRI represents the seventh hallmark of cancer, and suggests that an additional mechanism involved in cancer-related inflammation (CRI) is induction of genetic instability by inflammatory mediators, leading to accumulation of random genetic alterations in cancer cells.
Journal ArticleDOI

Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis

TL;DR: It is shown that platelet-tumor cell interactions are sufficient to prime tumor cells for subsequent metastasis and inhibit NF-κB signaling in cancer cells, resulting in their transition to an invasive mesenchymal-like phenotype and enhanced metastasis in vivo.
Journal ArticleDOI

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.

TL;DR: Benefit was greatest for cancers of the proximal colon, which are not otherwise prevented effectively by screening with sigmoidoscopy or colonoscopy, and benefit increased with scheduled duration of treatment.

Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis

TL;DR: In this article, platelet-tumor cell interactions are sufficient to prime tumor cells for subsequent metastasis, resulting in an invasive mesenchymal-like phenotype and enhanced metastasis in vivo.
Journal ArticleDOI

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

TL;DR: It is suggested that aspirin might help in treatment of some cancers and provides proof of principle for pharmacological intervention specifically to prevent distant metastasis in patients who developed cancer during trials of daily aspirin versus control.
Related Papers (5)